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Abstract
Aim The aim of this research is to examine the 6-month effects of an Internet-based guided self-help intervention for
comorbid depressive symptoms in people with diabetes.
Methods Participants (n = 260) with Type 1 or 2 diabetes and elevated depressive symptoms [Center for
Epidemiological Studies Depression Scale (CES-D) ≥ 23] were randomly assigned to a guided Internet-based self-help
intervention or a control condition (treatment as usual + online psychoeducation about depression). The primary
outcome was a change in depressive symptom severity (CES-D) from baseline to 6-month follow-up. The secondary
outcomes included numbers of people achieving treatment response (reliable change of depressive symptoms) and
remission (CES-D ≤ 16), as well as the effects on glycaemic control, diabetes-related emotional distress and diabetes
acceptance. Repeated measures analysis of variance examined between-group differences using intent-to-treat principles.
Results Both conditions showed improvements in depression severity: intervention condition, d = 1.48 [95%
confidence interval (95% CI): 1.21 to 1.76]; control condition d = 0.55 (95% CI: 0.30 to 0.80). Changes were
significantly greater in the intervention condition with a large between-group effect size (d = 0.83, 95% CI: 0.57 to
1.08). Accordingly, effects on response [relative risk (RR) = 2.60 (95% CI: 2.01 to 3.36), P < 0.001] and remission
[RR = 3.36 (95% CI: 2.98 to 5.44), P < 0.001] were in favour of the intervention group, as were differences in change in
diabetes emotional distress (d = 0.50, 95% CI: 0.04 to 0.54), and physical and mental functioning [Short Form Health
Survey (SF-12) Physical d = 0.27 (95% CI: 0.01 to 0.51) and SF-12 Mental d = 0.68 (95% CI: 0.11 to 0.40)]. The
intervention group was not superior with regard to glycaemic control, diabetes self-management and diabetes
acceptance.
Conclusions The trial indicates that Internet-based guided self-help treatments for depression in people with diabetes
can have sustained effects on depressive symptoms, well-being and emotional distress associated with diabetes.
Diabet. Med. 34, 99–107 (2017)
Introduction
Depression is highly prevalent and one of the leading
causes of disability worldwide. Individuals diagnosed with
diabetes have a greater risk of developing depression [1],
double the prevalence rate compared with people without
diabetes [2]. Compared with non-depressed people with
diabetes, people with diabetes and comorbid depression are
also more likely to report diabetes treatment non-adherence
[3], higher economic costs [4] and a higher mortality risk
[5].
Depression in diabetes can be treated effectively with
antidepressant medication [6], although there is no evidence
for the sustainability of the treatment effects in this popu-
lation [6]. However, many people do not adhere to
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prescription guidelines or refuse medication, and thus,
psychotherapy may be the preferred treatment option at
least in these people. A recent Cochrane review on the basis
of eight randomized trials provided evidence that psycho-
logical interventions can be an effective approach with
regard to short-term reduction of depressive symptoms
[standardized mean difference (SMD) = 1.47–0.14]; how-
ever, across these studies, there was significant heterogeneity
in treatment response. Moreover, research on the long-term
effects of psychological interventions is scarce. To the best of
our knowledge, only three randomized controlled trials
(RCTs) have been published that included follow-up assess-
ments of at least 6 months [7–9]. Results provided by these
studies are mixed and range from non-significant [8] and
small effects (3 points difference in BDI; SMD = 0.31) [7,8]
to significant and large effects (SMD = 1.1) [10]. Effects on
diabetes-related outcomes, such as glycaemic control and
diabetes management, also are mixed [11]. Thus, more
research is needed to clarify the longer term effects of
interventions targeting depression and diabetes-related out-
comes in people with depression and diabetes.
A core disadvantage of psychological interventions for
depression in diabetes is that they require well-trained mental
health professionals, which reduces the availability of such
interventions and increases their costs. Additionally, the
available treatment options might be underutilized because:
(1) there is often a stigma associated with pursing treatment
for mental illness, and (2) many individuals report insuffi-
cient time to pursue needed services. These are among the
many reasons why only a small percentage of people with
depression and diabetes receive proper treatment. For
example, in a recent survey in the USA, only 31% of people
with depression and diabetes reported receiving antidepres-
sive treatment, and only 6.7% reported receiving at least four
sessions of psychotherapeutic treatment [12].
A recent development that may help reduce this problem is
the use of Internet-guided self-help interventions. These
interventions offer a number of advantages. First, they may
attract people who do not want to make use of traditional
mental health services, and perhaps given the stigma attached
with traditional mental health services may not seek critical
care otherwise. Second, Internet interventions are easily
scalable; overcoming the challenge of finding mental health
professionals with proficient knowledge of both diabetes and
depression. Last, Internet-guided self-help interventions pro-
vides immediate accessibility [13,14].
The efficacy of Internet-guided self-help interventions for
the treatment of comorbid depression and diabetes has been
evaluated in only two RCTs [14–16]. Both trials found that
Internet-based interventions were effective in reducing
depressive symptoms in the short-term, with effects of
d = 0.29 [16] and d = 0.89 [17]. However, the longer term
effectiveness of these interventions on depression has not yet
been investigated. Thus, it is unclear whether post-treatment
effects are stable once the interventions are discontinued.
Moreover, the effects of these interventions on glycaemic
control are unclear. In the study by Bastelaar and colleagues,
the intervention failed to improve glycaemic control, and
these effects were not been reported in the study by Nobis
et al. [17].
The aim of this study is to test the 6-month effectiveness of
the GET.ON Mood Enhancer Diabetes intervention for
comorbid depression and diabetes and examine the effects of
these interventions on diabetes-specific outcomes.
Method
Design
A two-armed RCT was conducted to compare an Internet-
guided self-help intervention for depression intervention
condition and an active control condition (online psychoe-
ducation on depression) [15]. Assessments took place at
baseline (T1), post treatment (8 weeks, T2) and at 6-months
follow-up (6-MFU) (T3; see Fig. 1). Details of the trial design
[15] and short-term effects (pre–post changes) have been
reported previously [17]. All procedures were approved by
an independent ethics committee (DRKS00004748).
Participants and procedures
Participants were recruited from the general population via a
large German health insurance company, via mailings to
insured members of a diabetes disease management pro-
gramme and through newspaper articles, on-air media and
related websites. We included adults (≥ 18 years), with at
least moderate symptoms of depression [Center for Epidemi-
ological Studies Depression Scale (CES-D) ≥ 23] [18], with
Internet access and sufficient German language skills in
reading and writing. We excluded those with: (1) elevated
suicide risk [> 1 Beck Depression Inventory (BDI) item 9,
‘I feel I would be better off dead’]; (2) that were in an
What’s new?
• Data on the long-term effectiveness of treatments for
comorbid depression and diabetes are scarce.
• Depressive symptoms in people with diabetes are
undertreated.
• Results provide support for sustained benefits of Inter-
net-based guided self-help for comorbid depressive
symptoms and diabetes.
• Internet-based guided self-help could be one among
other strategies to reduce the gap between the need for
evidence-based treatments and their availability for
people with comorbid depression and diabetes.
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ongoing psychotherapeutic treatment; or (3) on a waiting list
for such a psychotherapeutic treatment. In addition, we
included a telephone-administered Structured Clinical
Interview (SCID) to measure actual and past presence and
of depressive episodes. Participants eligible for inclusion who
provided their informed consent were randomly allocated to
Interven ons 
Analysed  ITT (n=127)
♦ Excluded from analysis 
n=4 withdrawn consent for data use
 
Analysed  ITT (n=128)
♦ Excluded from analysis 
n=2 withdrawn consent for data use
 
Assessed for eligibility (n=413)
Excluded  (n=153)
♦   Not meeting inclusion criteria (n=129)
- low depression score (n=90, mean CES-
D:17)
- current psychotherapy (n=17)
- risk of suicide (n=10)
- waiting list for psychotherapy (n=8)
- diagnose diabetes less than 3 months (n=4)
Analysed  ITT (n=129)
♦ Excluded from analysis 
n=1 withdrawn consent for data use
 
Lost to follow-up (n=31)
Finished intervention (n=80)
Discontinued intervention (n=50)
Allocated to intervention (n=130)
♦ Received allocated intervention (n=130) 
 
Lost to follow-up (n=16)
Allocated to intervention (n=130)
♦ Received allocated intervention (n=130 ) 
 
Analysed  ITT (n=127)
♦ Excluded from analysis 






Lost to follow-up (n=50)
 
 





FIGURE 1 CONSORT flow chart
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study conditions at an individual level. The allocation was
performed by an independent researcher, not otherwise
involved in the study, using an automated computer-based
random integer generator (randlist) with a block size of 2.
Interventions
Intervention condition
Participants of the intervention group received GET.ON
Mood Enhancer Diabetes (for a detailed description see Ref.
[15]). In brief, it is an online training with six sessions based
on two core evidence-based treatment components (be-
havioural activation and problem solving). Two optional
sessions address weight and sleeping problems. A seventh
booster session (4 weeks after completion of the last session)
aims at supporting participants to transfer skills into daily
life routine. Each session addresses the reciprocal relation-
ship between diabetes and depression. Weekly sessions
can be completed in ~ 45–60 min. Within 48 h after session
completion, participants received personalized written feed-
back from trained psychologists.
Control condition
Individuals in the control condition had full access to treat-
ment as usual and were additionally offered self-help Internet-
based psychoeducation on the same platform. Psychoeduca-
tion was based on the patient version of the German S3-
Guideline/National Disease Management Guideline Unipolar
Depression. It informed participants about the nature and
evidence-based treatments of depression. We did not monitor
the actual uptake of the intervention. Passive psychoeduca-
tional interventions have been shown to be effective in
reducing depressive symptoms in non-medical patients with
a pooled standardized-effect size of d = 0.26 [19].
Outcome measures
Primary outcome
The primary outcome was the depressive symptom severity,
as measured by CES-D [18]. This widely used scale consists
of 20 items. Subjects rate the frequency of symptoms (e.g.
‘During the past week I felt sad.’) during the past week on a
4-point Likert-scale (from 0 ‘rarely – less than one day’ to 3
‘most of the time – five to seven days’). The total score varies
between 0 and 60. Evidence for the reliability, validity and
sensitivity to change of the scale comes from several studies).
Cronbach’s alpha for this study was 0.91.
Secondary outcomes
In secondary analysis, the effects on the below-mentioned
outcomes are reported. Higher scores indicate greater
impairment, unless otherwise specified. Secondary outcomes
include:
 glycaemic control (HbA1c values);
 depressive symptoms (Hospital Anxiety and Depression
Scales, HADS, which is especially suited for the use in
somatic patients, HADS-D; 7 items; range 0–21; a = 0.86)
[20];
 physical and mental functioning (Short Form Health
Survey, SF-12, 12 items; range 0–100) [21];
 emotional distress related to living with diabetes (Problem
Areas in Diabetes scale, PAID, 5 items, range 0–20;
a = 0.88) [22];
 coping with diabetes (Acceptance and Action Diabetes
Questionnaire, AADQ, 7 items, range 11–77; a = 0.77,
higher values indicate higher acceptance) [23]; and
 diabetes self-care (Diabetes Self-Management Question-
naire, DSMQ, 16 items, range 0–10, a = 0.77) [24].
Statistical analysis
Analyses are reported according to the Consolidated Stan-
dards of Reporting Trials statement. Based on a pre-trial
power calculation, we included 260 participants to detect a
between trial arm effect size for depressive severity of
d = 0.35, with a power (1  b) of 0.8 in a two-tailed test
and an alpha of 0.05. Data were analysed according to intent-
to-treat principles (ITT).We usedMarkovChainMonteCarlo
multivariate imputation algorithm (missing data module in
SPSS 20)with 10 estimations permissing value to deal with the
missing data. Additionally, completer’s only analyses are
reported, including only participants with available data.
Analyses were performed with IBM SPSS version 22. A
significance level of 0.05 (two-tailed) was used for all analyses.
Differences in change in depressive symptoms and other
continuous secondary outcomes between intervention group
and control group were assessed using analyses of covariance
(ANCOVAs) with the respective baseline scores as covari-
ates. Model assumptions for conducting ANCOVAs were
met. Within and between group Cohen’s d values and 95%
confidence intervals (95% CI) were calculated. According to
Cohen’s d: 0.2 equals a small effect, 0.5 equals a medium
effect and 0.8 equals a large effect. We included concurrent
use of antidepressants, age, duration of diabetes and family
status and use of other psychological treatments during the
trial period as covariates in the primary outcome analysis.
Because none of these variables was a predictor of the
outcome, we excluded them from the final model. To
determine the numbers of participants achieving a reliable
positive outcome we coded participants as responders
according to the widely used Reliable Change Index (RCI)
[25]. Participants with a reliable positive change in depres-
sion (RCI ˃ 1.96; ≥ 8.99 CES-D points) were classified as
‘responders’. We examined the maintenance of gains from
post treatment to the 6-MFU to investigate whether main-
tenance treatments following treatment discontinuation are
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indicated. Post-treatment responders were classified as
‘deteriorated’ if their symptoms increased from post treat-
ment to 6-MFU by 8.99 CES-D points. Participants were
classified as ‘relapsed’ if remitters at post treatment reported
a symptom deterioration above a score of 23 on the CES-D at
the 6-MFU. In addition, we considered whether participants
attained a near-to-symptom-free state. In the absence of
reliable cut-off scores for remission on the CES-D, we
applied Jacobsen’s method to define a near-to-symptom-free
state [25]. Accordingly, participants were classified as remit-
ters, if they moved two standard deviations below the mean
of the clinical group. This procedure resulted in a cut-off
score of ≤ 16. The cut-off for clinical relevant symptoms in
the German version of the CES-D is 23. Moreover, we
considered whether participants were classified as being in
the target range of HbA1c values < 53 mmol (7%), as
recommended by the American Diabetes Association. We
also calculated RR and the numbers needed to be treated
(NNT) in order to achieve one additional positive outcome
compared with the control group and its 95% CI.
Results
Sample
The flow of participants is summarized in Fig. 1. Detailed
demographic and clinical characteristics can be found in
Table 1, and information pertaining to primary and sec-
ondary outcome measures are included in Table 2. Partici-
pants had high levels of diabetes-specific emotional distress
at baseline as indicated by a mean > 10.4 (SD = 4.4) on the
PAID, but were overall well controlled for HbA1c at baseline
(mean values of 58 mmol/mol, 7.5%). After 6 months, study
attrition for the full sample was 29% (n = 74). Participants
who did not provide data at one of the follow-up assessments
did not differ from participants without missing data on
baseline depression severity scores or any other baseline
characteristics (all P-values > 0.10). The vast majority
(n = 80; 74%) finished all six sessions. In addition, treatment
completers did not significantly differ from non-completers
on any of the assessed baseline variables.
Changes in primary and secondary outcomes from baseline
to 6-MFU
Table 3 displays the results of ANCOVAs with the respective
baseline value as covariate for all of the outcome measures.
With regard to the primary outcome depression severity,
there was a significant group effect (P ˂ 0.001) indicating
significant greater improvements in depression severity from
baseline over time in the intervention condition compared
with the control condition (CES-Dpre-6-MFU = 12.4,
dwithin = 1.48, 95% CI: 1.2 to 1.8; control condition: CES-
Dpre-6-MFU = 4.7; P < 0.001; dwithin = 0.55, 95% CI: 0.3 to









Age (mean, SD) 50.8 (11.8) 50.3 (11.7) 51.4 (11.9)
Female, n (%) 114 (44.5) 82 (63.6) 80 (63.2)
Employed. n (%) 142 (55.5) 70 (54.4) 72 (56.7)
College degree, n (%) 114 (44.5) 51 (39.5) 63 (49.6)
Ethnicity Caucasian, n (%) 190 (74.2) 96 (74.4) 94 (74.0)
Married or in a relationship, n (%) 160 (62.6) 85 (65.9) 75 (59.1)
Diabetes-related characteristics
Diabetes Type 2, n (%) 142 (55.) 64 (49.6) 78 (61.4)
Insulin-treated Type 2, n (%) 54 (21.1) 28 (21.7) 26 (20.5)
Duration of diabetes, 3–12 months, n (%) 18 (7.0) 10 (7.8) 8 (6.2)
Duration of diabetes, 1–10 years, n (%) 119 (46.5) 57 (44.2) 62 (48.1)
Duration of diabetes, ˃ 10 years, n (%) 119 (46.5) 62 (48.1) 57 (44.9)
Diabetes complications, n (%) 63 (24.6) 33 (25.6) 30 (23.6)
PAID score (mean, SD) 10.41 (4.4) 10.25 (4.3) 10.6 (4.5)
HbA1c, mmol/mol (%) 58 (7.5) 60 (7.6) 57 (7.4)
Depression
CES-D score (mean, SD) 31.9 (7.2) 32.17 (7.0) 31.5 (7.5)
Major depressive disorder, n (%) 61 (23.8) 35 (27.1) 26 (20.6)
Recurrent major depression, n (%) 78 (30.5) 38 (29.5) 40 (31.5)
Major Depressive Disorder, currently
partial remission, n (%)
87 (34.0) 42 (32.6) 45 (35.4)
Antidepressant use, n (%) 12 (4.7) 4 (3.1) 8 (6.3)
Experience with psychotherapy, n (%) 102 (40) 49 (38) 53 (42)
Use of psychological treatments after
start of trial, n (%)
11 (9) 15 (12) 26 (9.85)
CES-D, Center for Epidemiological Studies Depression Scale; PAID, Problem Areas in Diabetes scale.
PAID: A total score of ≥ 8 indicates diabetes-related emotional distress.
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0.8). Differences in changes were large (dbetween = 0.83, 95%
CI: 0.6 to 1.1). See Fig. 2 for a graphical representation of
the course of depressive symptoms over time.
With regard to the secondary outcomes, there were
significant effects in favour of the intervention condition
for all outcomes except for HbA1c, diabetes self-management
and diabetes acceptance. Diabetes acceptance results in a
significant negative effect of the treatment (d = 0.42, 95%
CI: 0.1 to 0.5). There was no significant effect of the
intervention on diabetes self-management (d = 0.18, 95%
CI: 0.2 to 0.3) and numbers of people within the target
range for glycaemic control (d = 0.15, 95% CI: 0.0 to 0.5).
Response, remission and deterioration
Depression response, remission and deterioration rates are
included in Table 4. Significantly more participants in the
intervention condition were classified as responders at 6-
MFU compared with the control condition, with a RR of 2.6
(95% CI: 2.0 to 3.4) and a NNT in order to achieve one
additional treatment response of 2.6 (95% CI: 2.4 to 3.7).
Remission rates also were significantly and in favour of the
intervention condition, with a RR of 3.4 (95% CI: 3.90 to
5.4) and a NNT of 3.1 (95% CI: 1.4 to 4.7).
Completers only
Completers only analysis including only those participants
who completed all assessments for the primary outcome at 6-
MFU (n = 182, 71%) confirmed the robustness of the
findings. Similar to the ITT analysis, an effect size of
d = 0.76 (CI: 0.5 to 1.1) was observed for changes in the
primary outcome measure from baseline to 6-MFU. Effect
sizes for secondary outcomes showed similar patterns as
Table 2 Means (M) and standard deviations (SD) of outcome variables at baseline, post treatment and 6-months follow-up (intention-to-treat
sample)
Outcome
Baseline Post-treatment 6-months follow-up
IG CG IG CG IG CG
M SD M SD M SD M SD M SD M SD
CES-D 32.2 7.0 31.5 7.5 21.1 8.8 28.9 8.7 19.8 9.6 26.8 9.4
HADS 12.0 3.2 11.7 3.1 8.1 3.9 11.3 3.7 7.4 4.1 10.3 4.0
PAID 10.3 4.3 10.6 4.5 8.4 3.9 10.9 4.7 8.1 4.2 9.9 4.5
HbA1c nmol/mol (%) 60 (7.6) 1.6 57 (7.4) 1.3 – – – – 60 (7.6) 1.6 57 (7.4) 1.4
DSMQ 4.8 0.7 4.7 0.7 4.8 0.6 4.7 0.6 4.6 0.5 4.7 0.6
AADQ 36.9 9.0 36.6 10.3 34.1 8.5 36.1 9.9 33.8 7.7 37.3 9.5
SF-12: Physical 40.1 11.0 42.0 10.6 42.0 10.8 42.1 11.4 41.9 10.9 41.3 10.0
SF-12: Mental 31.2 7.5 32.0 8.6 40.1 9.2 33.3 9.1 42.5 9.1 37.3 9.9
IG, Intervention group; CG, Control group; CES-D, Center for Epidemiological Studies Depression Scale; HADS, Hospital Anxiety and
Depression Scale; PAID, Problem Areas in Diabetes scale; DSMQ, Diabetes Self-Management Questionnaire; AADQ, Acceptance and Action
Diabetes Questionnaire; SF-12: Physical, Short Form Health Survey (Physical Health Summary Scale); SF-12: Mental, Short-Form Health
Survey (Mental Health Summary Scale).
Table 3 Within- and between-group effect sizes for baseline to follow-up changes and ANCOVAs for differences in change in primary and




to 6 month follow-up Between-group changes
effect T3b
Fc P dIC,within dCC,within dbetween
CES-D 55.39 < 0.001 1.48 (1.2 to 1.8) 0.55 (0.3 to 0.8) 0.83 (0.6 to 1.1)
HADS-D 57.37 < 0.001 1.25 (1.0 to 1.5) 0.39 (0.1 to 0.6) 0.86 (0.0 to 0.5)
PAID 17.78 < 0.001 0.52 (0.3 to 0.8) 0.14 (0.1 to 0.4) 0.50 (0.0 to 0.5)
HbA1c 0.0 0.99 0.01 (0.2 to 0.3) 0.02 (0.3 to 0.2) 0.15 (0.0 to 0.5)
DSMQ 2.28 0.13 0.26 (0.0 to 0.5) 0.02 (0.3 to 0.2) 0.18 (0.2 to 0.3)
AADQ 6.08 < 0.001 0.38 (0.6 to 0.1) 0.08 (0.2 to 0.3) 0.42 (0.1 to 0.5)
SF-12: Physical 2.23 0.13 0.17 (0.1 to 0.4) 0.07 (0.3 to 0.2) 0.27 (0.0 to 0.5)
SF-12: Mental 29.96 < 0.001 1.37 (1.1–1.6) 0.53 (0.3 to 0.8) 0.68 (0.1 to 0.4)
CES-D, Center for Epidemiological Studies Depression Scale; HADS-D, Depression subscale from the Hospital Anxiety and Depression Scale;
PAID, Problem Areas in Diabetes scale; DSMQ, Diabetes Self-Management Questionnaire; AADQ, Acceptance and Action Diabetes
Questionnaire; SF-12: Physical, Short-Form Health Survey (Physical Health Summary Scale); SF-12: Mental, Short-Form Health Survey
(Mental Health Summary Scale).
aControlling for pre-treatment scores (T1). bMissing data imputed by multiple imputation. cDegrees of freedom not provided due to multiple
imputation.
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those found in the ITT analysis. The significant positive effect
sizes were d = 0.81 for the HADS (95% CI: 0.1 to 0.6),
d = 0.51 for the PAID (95% CI: 0.1 to 0.7), d = 0.56 for
the SF-12 MCS (95% CI: 0.2 to 0.4), and d = 0.31 for the
SF-12 PCS (95% CI: 0.1 to 0.5). No significant effect sizes
were found for HbA1c (d = 0.09, 95% CI: 0.0 to 0.6) and
diabetes self-management (d = 0.17, 95% CI: 0.1 to 0.5).
Changes in diabetes acceptance were in favour of the control
condition (d = 0.36, 95% CI: 0.1 to 0.5).
Maintenance of treatment effects from post treatment to 6-
MFU
Of the 81 responders at post treatment in the intervention
group, 10 (12.3%) experienced symptom deterioration from
post treatment to 6-MFU, whereas this was the case for 5
(20.8%) of the 24 responders in the control group (P > 0.10).
Depression relapse was experienced by 2 of 40 post-
treatment remitters (5%) in the intervention condition, and
1 of 10 remitters in the control condition (10%, P > 0.10).
Discussion
The findings for the 6-month effect on depression severity
compare favourably with the few trials of face-to-face
psychological interventions in comorbid depression and dia-
betes that examined long-term effects (6 months +) [8–10].
Specifically, face-to-face cognitive–behavioural psychother-
apy had large effects on depression severity at follow-up
compared with diabetes education only [10]. However,
another study found only small effects [7] and a recently
published study [8] did not find psychotherapy to be superior
over usual care in the long term, although this might be
related to low power resulting from a small sample size
(N = 87).
The clinical significance of the results is further supported
by the effects on response (64.2% vs. condition: 28.6%,
RR = 2.6) and remission (45.3% vs. 13.5%, RR = 3.4),
which are comparable with post-treatment event rates found
in a recent meta-analysis for face-to-face psychotherapy for
depression compared with control conditions in non-medical
populations (Response: 48% vs. 19%; Remission: 43% vs.
27%) [25]. Moreover, differences in response and remission
rates are higher than those found in a recent meta-analysis
for short-term effects of collaborative care management
programmes for depression and diabetes compared with
treatment as usual (Response: RR = 1.3, 95% CI = 1.1 to
1.7; Remission: RR = 1.5, 95% CI = 1.1 to 2.1) [26].
Although emotional distress regarding living with diabetes
decreased, in contrast to our hypothesis, diabetes self-care,
diabetes acceptance and glycaemic control did not improve.
This finding is consistent with a number of previous studies
that found psychological interventions to be not superior to
usual care with regard to these outcomes [27,28]. Notwith-
standing our non-significant findings, there are at least two
randomized trials that found significant effects of psy-
chotherapy on glycaemic control [8,26]. One explanation
for these differences is that these psychotherapeutic inter-
ventions incorporated specific modules for improved dia-
betes management [11]. It is noteworthy, that in the
Lustman study, the comparator condition was self-care
for diabetes and the effects of psychotherapy in addition to
diabetes self-care were nevertheless greater compared with
self-care alone on glycaemic control. This may indicate that
the combination of interventions for depression and dia-
betes self-care may interact to potentiate the effect on
glycaemic control. This is in line with the assumption that
depression treatment might be necessary to improve gly-
caemic control, but not sufficient [8]. To test this
Table 4 Even rates and effects on response and remission at 6-month follow-up
ERIC ERCC
RR 95% CI P NNT 95% CI% n % n
Response 64.2 86 28.6 2.6* 2.0 to 3.4 < 0.001 2.6 2.4 to 3.7
Remission 45.3 58 13.5 17 3.4* 3.0 to 5.4 < 0.001 3.1 1.4 to 4.7
Deterioration 0.8 1 3.2 4 0.2 0.0 to 2.2 0.19
ER, event rate: numbers of participants displaying response and remission, respectively. IC, intervention condition; CC, control condition;
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FIGURE 2 Course of depressive symptoms over time
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hypothesis, future trials should compare psychotherapy in
addition to diabetes self-care with diabetes self-care alone
and with psychotherapy alone. It should also be noted that
mean diabetes self-care (4.75 across groups) was not
problematic at baseline (> 6), and also the mean HbA1c
value 58 (7.5%) across groups was already close to target
at baseline.
Limitations of the study include the following. First, there
was a drop-out rate of 28% at the 6-MFU. Although such
attrition rates are common in follow-up studies of RCTs, we
applied state-of-the-art methods to handle missing data.
Nevertheless, we cannot rule out a potential bias due to
missing data. Second, we did not conduct clinical interviews
at the follow-up assessments, thus do not know whether
diagnostic status has changed as a result of the intervention.
Third, the block size in the randomization was 2 which is a
potential source of bias. However, none of the research staff
ever met the participants, participants were randomized in
order of incoming informed consent, the researcher respon-
sible for randomization was independent, not otherwise
involved in the study, and did not have any information such
as baseline characteristics of the participants. Finally, sleep
and exercise were targeted within optional modules of the
intervention, but we did not assess insomnia severity or
weight as outcome, which should be considered in future
studies.
Despite these limitations, our data suggest that Internet-
based guided self-help for comorbid depression and diabetes
is an effective approach that can result in sustained 6-month
benefits. Internet-guided self-help interventions may be
successfully integrated in existing diabetes care management
or collaborative care programmes [26]. Thus, Internet
interventions could be one among other strategies to reduce
the gap between the need for evidence-based treatments and
their availability for people with comorbid depression and
diabetes. However, the acceptance of an intervention by the
target population is always a necessary prerequisite for
utilizing it and not all people might be willing to use Internet-
guided self-help interventions [30]. Hence, we argue that
these interventions should be offered as only one treatment
option along with already established interventions for
depression in people with diabetes.
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